The World Health Organization and Gavi, the Vaccine Alliance have invited developing countries such as Ghana, Kenya, and Malawi to apply for funding to access the RTS,S malaria vaccine.
International assistance worth $160 million (£133 million) will be made available to the aforementioned countries, which piloted the vaccine in 2019.
Other malaria-affected countries can apply for funding beginning in September.
WHO recommended widespread use of the RTS,S vaccine in October 2021, prompting more countries to express interest in it, nevertheless, the supply remains limited in the continent.
Since the vaccine’s pilot program began in 2019, approximately 1.3 million children have received at least one of the required four doses, however, the jab only provides 30% protection.
According to the WHO, Africa requires at least 80 to 100 million doses per year.
A manufacturer of GlaxoSmithKline (GSK), says it can only produce about 15 million doses every year until 2028.
